PATENT CLAIM ANALYSIS

Application Number: 16176958
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["514", "185000"]

Abstract:
The present disclosure relates to methods of treating a range of diseases or conditions. The methods involve administration of a superoxide dismutase mimetic.

Claim (Index 61):
The medicament of  claim 42 , wherein the superoxide dismutase mimetic is administered to the patient up to twelve weeks after the radiation therapy or chemotherapy.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.31579
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13625617', '14837831', '12993140', '15751495', '15841586']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7849240345888938
- 35 USC 102 Novelty (BERT): 0.5513245485812446
- Combined Prediction Score: 0.7615640859881289
- Mean Citation Score: 295.379324
- Max Citation Score: 425.81418
- Similarity Product: 302.60759952239164

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test